Nils Kucher
Elite in Pulmonary Embolism

Nils Kucher

Zurich, ZH, CH 
Elite in Pulmonary Embolism
Zurich, ZH, CH 
OverviewLocationsClinical Research

Overview

Nils Kucher practices in Zurich, Switzerland. Mr. Kucher is rated as an Elite expert by MediFind in the treatment of Pulmonary Embolism. His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy.

His clinical research consists of co-authoring 161 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 49 articles and participated in 2 clinical trials in the study of Pulmonary Embolism.

Gender
Male

Locations

Zurich, ZH, Switzerland
Other Locations
Bern, BE, Switzerland
Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2025
Intervention Type: Device
Study Drug: Sirolimus
Study Phase: Not Applicable
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With Post-thrombotic Syndrome a Multi-center, International, Randomized, Open Label, Controlled Trial
Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With Post-thrombotic Syndrome a Multi-center, International, Randomized, Open Label, Controlled Trial
Enrollment Status: Terminated
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 2
Retrospective and Prospective International EkoSonic® Registry of the Treatment and Clinical OUTcomes of Patients With Pulmonary Embolism
Retrospective and Prospective International EkoSonic® Registry of the Treatment and Clinical OUTcomes of Patients With Pulmonary Embolism
Enrollment Status: Completed
Publish Date: February 22, 2023
Intervention Type: Device
Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial
Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With Coronavirus: The Multicenter Randomized Controlled Ovid Trial
Enrollment Status: Terminated
Publish Date: May 25, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
View 3 Less Clinical Trials

161 Total Publications

Anticoagulation for heparin-induced thrombocytopenia before, during, and after peripheral endovascular procedures.
Anticoagulation for heparin-induced thrombocytopenia before, during, and after peripheral endovascular procedures.
Journal: VASA. Zeitschrift fur Gefasskrankheiten
Published: August 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kucher's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile